An Exon splice enhancer mutation causes autosomal dominant GH deficiency

被引:88
作者
Moseley, CT
Mullis, PE
Prince, MA
Phillips, JA
机构
[1] Vanderbilt Univ, Sch Med, Dept Pediat, Div Genet, Nashville, TN 37232 USA
[2] Univ Bern, Inselspital, Childrens Hosp, Dept Endocrinol, CH-3010 Bern, Switzerland
关键词
D O I
10.1210/jc.87.2.847
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial isolated GH deficiency type II (IGHD II) is caused, in some cases, by heterogeneous IVS3 mutations that affect GH mRNA splicing. We report here our finding an A-->G transition of the fifth base of exon 3 (E3+ 5 A-->G) in affected individuals from an IGHD II family. This mutation disrupts a (GAA) exon splice enhancer (ESE) motif immediately following the weak IVS2 3' splice site. The mutation also destroys an MboII site used to demonstrate heterozygosity in all affected family members. To determine the effect of ESE mutations on GH mRNA processing, GH(3) cells were transfected with expression constructs containing the normal ESE, +5 A-->G, or other ESE mutations, and cDNAs derived from the resulting GH mRNAs were sequenced. All ESE mutations studied reduced activation of the IVS2 3' splice site and caused either partial E3 skipping, due to activation of an E3+ 45 cryptic 3' splice site, or complete E3 skipping. Partial or complete E3 skipping led to loss of the codons for amino acids 32-46 or 32-71, respectively, of the mature GH protein. Our data indicate that the E3+ 5 A-->G mutation causes IGHD II because it perturbs an ESE required for GH splicing.
引用
收藏
页码:847 / 852
页数:6
相关论文
共 26 条
[1]  
[Anonymous], J CLIN ENDOCRINOL ME
[3]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[4]   THE HUMAN GROWTH-HORMONE LOCUS - NUCLEOTIDE-SEQUENCE, BIOLOGY, AND EVOLUTION [J].
CHEN, EY ;
LIAO, YC ;
SMITH, DH ;
BARRERASALDANA, HA ;
GELINAS, RE ;
SEEBURG, PH .
GENOMICS, 1989, 4 (04) :479-497
[5]   A novel mechanism of aberrant pre-mRNA splicing in humans [J].
Cogan, JD ;
Prince, MA ;
Lekhakula, S ;
Bundey, S ;
Futrakul, A ;
McCarthy, EMS ;
Phillips, JA .
HUMAN MOLECULAR GENETICS, 1997, 6 (06) :909-912
[6]   A RECURRING DOMINANT-NEGATIVE MUTATION CAUSES AUTOSOMAL-DOMINANT GROWTH-HORMONE DEFICIENCY - A CLINICAL RESEARCH-CENTER STUDY [J].
COGAN, JD ;
RAMEL, B ;
LEHTO, M ;
PHILLIPS, J ;
PRINCE, M ;
BLIZZARD, RM ;
DERAVEL, TJL ;
BRAMMERT, M ;
GROOP, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3591-3595
[7]   FAMILIAL GROWTH-HORMONE DEFICIENCY - A MODEL OF DOMINANT AND RECESSIVE MUTATIONS AFFECTING A MONOMERIC PROTEIN [J].
COGAN, JD ;
PHILLIPS, JA ;
SCHENKMAN, SS ;
MILNER, RDG ;
SAKATI, N .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05) :1261-1265
[8]   The regulation of splice-site selection, and its role in human disease [J].
Cooper, TA ;
Mattox, W .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) :259-266
[9]   HUMAN GROWTH-HORMONE AND EXTRACELLULAR DOMAIN OF ITS RECEPTOR - CRYSTAL-STRUCTURE OF THE COMPLEX [J].
DEVOS, AM ;
ULTSCH, M ;
KOSSIAKOFF, AA .
SCIENCE, 1992, 255 (5042) :306-312
[10]  
Kamijo T, 1999, GROWTH HORM IGF RES, V9, P35